Here are 16 key notes on orthopedic and spine device companies over the past week.
Fortune named Arthrex one of the 15 best workplaces for manufacturing and production in the United States.
ConforMIS reported its fourth quarter and full year 2015 results. Total revenue for the quarter reached $19.1 million.
LDR had total revenue of $164.5 million for 2015, compared to $141.3 million for 2014.
Materialise NV signed an agreement with Swiss orthopedic producer Mathys for the use of Materialise's Shoulder Guide System.
Mazor Robotics' fourth quarter revenue hit $8.8 million, a 54 percent increase over the same period in 2014.
Medtech sold another ROSA robotic surgery system to a hospital in France.
A clinical trial showed Mesoblast's MPC-300-IV was safe and results in early and sustained clinical responses for patients with biologic refractory rheumatoid arthritis.
Regentis Biomaterials closed a series D investment round on Feb 5.
RTI Surgical had fourth quarter revenues of $76.1 million, which was a 7 percent increase over the same period in 2014.
SI-BONE reported the National Government Services, a Medicare Administrative Contractor, issued a positive local coverage determination for MIS SI joint fusion, effective April 1, 2016.
Hospital Corporation of America awarded a national vendor contract to SpineGuard.
Stryker signed a deal to acquire Physio-Control in a $1.28 billion all-cash transaction.
The FDA approved Chicago-based St. Jude Medical's Axium Neurostimulator System for dorsal root ganglion stimulation.
Titan Spine saw a 51 percent increase in sales of its Endoskeleton interbody fusion devices in 2015.
ulrich medical USA reported a 20 percent top line growth for 2015.
VirtaMed developed a virtual reality simulation for ACL reconstruction.